Steward Partners Investment Advisory’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4K Hold
900
﹤0.01% 3360
2025
Q4
$15.3K Hold
900
﹤0.01% 3246
2025
Q3
$18.8K Hold
900
﹤0.01% 3116
2025
Q2
$15.2K Hold
900
﹤0.01% 3025
2025
Q1
$14K Buy
+900
New +$13.2K ﹤0.01% 2950
2022
Q1
Sell
-1,000
Closed -$29K 3332
2021
Q4
$29K Hold
1,000
﹤0.01% 2161
2021
Q3
$37K Hold
1,000
﹤0.01% 2035
2021
Q2
$46K Hold
1,000
﹤0.01% 3554
2021
Q1
$38.9K Buy
+1,000
New +$40.9K ﹤0.01% 2113

Other funds holding KURE

Steward Partners Investment Advisory's KURE Position: Q1 2026 in Review

Steward Partners Investment Advisory held its KraneShares MSCI All China Health Care Index ETF (KURE) position steady in Q1 2026 at 900 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3360.

Steward Partners Investment Advisory first reported a position in KURE in Q1 2021 and has held it in 9 quarters since. The position peaked at $46K in Q2 2021. 16 funds tracked by Wall St. Rank hold KURE as of Q1 2026.

  • Steward Partners Investment Advisory held 900 shares of KraneShares MSCI All China Health Care Index ETF worth $15.4K as of Q1 2026.
  • Steward Partners Investment Advisory left its KraneShares MSCI All China Health Care Index ETF share count unchanged in Q1 2026.
  • KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3360 holding.
  • Steward Partners Investment Advisory first reported a position in KraneShares MSCI All China Health Care Index ETF in Q1 2021 and has held it in 9 quarters since.
  • Steward Partners Investment Advisory's KraneShares MSCI All China Health Care Index ETF position peaked at $46K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.